Tilray's Beverage Engine Outpaces Cannabis as Traders Circle a Beaten-Down Stock
Published on 08/04/2026 at 18:04 | Redaktion boerse-global.de
The options market is flashing signals on Tilray Brands, and the chatter isn't just about weed anymore. Just days after the company reported fiscal fourth-quarter results, unusual derivatives activity has emerged alongside a modest equity bounce — a combination that suggests investors are positioning for a turning point in a stock that has spent much of the year in the doldrums.
Shares of the cannabis and consumer goods conglomerate traded between $4.59 and $4.94 on August 3, closing near the top of that range at $4.83. That marked a roughly 5 percent recovery from the session's low and extended a two-day winning streak that began with a 5.3 percent gain, followed by a 6.4 percent jump at the open the next day. CNN data showed the stock climbing 6.61 percent to an opening price of $4.60, six cents above the prior close.
The bounce, however, comes from a deeply depressed base. Tilray shares had recently broken below the $5.96 level — a floor that had held since March — and remain mired near 52-week lows. The stock's range over the past year stretches from $3.67 to $23.20, and it continues to trade beneath both its 50-day and 200-day moving averages. At current levels, the company's market capitalization sits at roughly $706 million, with a price-to-earnings ratio of negative 4.22.
Options Traders Place Their Bets
The derivatives action has caught the attention of market watchers. CNN flagged "unusually active options classes" on Tilray as a top story at the start of trading on August 3, following a TipRanks report highlighting fresh investor interest in the company's global expansion strategy.
Should investors sell immediately? Or is it worth buying Tilray?
One position stands out: a block of put options expiring in January 2027 with a $1 strike price changed hands across 80 separate trades, totaling 767 contracts. The seller of those puts collected $36,800 in premiums — a bearish wager that the stock will stay above $1 for the next several years, or a bet on volatility itself.
This activity follows a turbulent stretch around the earnings release on July 28, when options pricing implied a potential 10.7 percent swing in the stock following the report. Trading volume on August 3 reached 2.87 million shares, below the daily average of 5.6 million.
The Beverage Business Takes the Wheel
The recent optimism isn't?? — it's grounded in a fundamental shift in Tilray's revenue mix. For fiscal 2026, non-cannabis segments generated 71 percent of total revenue, with beverages and distribution leading the charge. In the quarter, beverages and distribution contributed $50.9 million of the $57.2 million in revenue growth. The beverage segment expanded by 61 percent year-over-year, distribution grew 15 percent, while cannabis — the company's original core — managed just 5 percent growth.
But the profitability picture tells a more nuanced story. Cannabis accounted for only 29 percent of revenue yet delivered 41 percent of gross profit. The legacy business remains disproportionately lucrative, even as it shrinks relative to the rest of the portfolio.
CEO Irwin Simon framed the transformation in broad terms. "The next chapter for Tilray will not be defined by a single product, a single market, or a single regulatory event," he said alongside the results. Management has guided for adjusted EBITDA between $68 million and $75 million in fiscal 2027, with revenue expected to cross the billion-dollar threshold — though the company declined to offer a specific revenue forecast.
Wall Street Remains Split
Despite the share price recovery, the analyst community hasn't rushed to embrace the stock. FactSet data shows three buy ratings and six hold ratings, with zero sell recommendations. The median price target stands at $5, roughly 12 percent above the current trading level.
The average target of $7.47 paints a more bullish picture, but that figure is skewed by an outlier target of $19. At the low end, one analyst sees the stock at $4.25. Recent reaffirmations include Derek Lessard at TD Cowen (buy, $5 target), Frederico Gomes at ATB (hold, $8 target), and Aaron Grey at Alliance Global (hold, $5 target).
Tilray at a turning point? This analysis reveals what investors need to know now.
Earnings estimates have deteriorated in the meantime. Analysts now project a loss of $0.47 per share for fiscal 2027, down from a previous estimate of minus $0.39 a month ago.
Cash Burn Remains the Elephant in the Room
The revenue story may be improving, but Tilray's cash consumption continues to raise eyebrows. GAAP operating cash flow came in at negative $69.1 million, while free cash flow reached negative $98.6 million. The adjusted free cash flow figure was negative $86.0 million. While these numbers show clear improvement from prior quarters, the company is still burning through significantly more cash than its adjusted earnings metrics suggest.
The balance sheet, however, looks more stable. As of the end of May, Tilray held approximately $235 million in cash, restricted cash, and marketable securities. Net debt by the company's own definition stands at just $0.7 million, though gross debt actually totals about $227 million. Add in $171.5 million in lease obligations, plus roughly $490 million tied up in inventory and receivables, and the picture emerges of a company with substantial capital locked in operations.
For now, the market appears willing to give Tilray credit for its diversification push. Whether that sentiment holds will depend on the company's ability to hit its 2027 EBITDA target and close the gap between adjusted profitability and actual cash generation — a gap that options traders, with their January 2027 puts, seem to be watching closely.
Ad
Tilray Stock: New Analysis - 4 August
Fresh Tilray information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
